510(k) K012183
K012183 is an FDA 510(k) premarket notification submitted by Bayer Diagnostics Corp. for the device "BAYER DIAGNOSTICS ADVIA CENTAUR TOXOPLASMA IGG ASSAY". The FDA issued a decision of Substantially Equivalent on Dec 27, 2001. The device falls under product code LGD (Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii), a Class II device regulated under 21 CFR 866.3780. Bayer Diagnostics Corp. has 31 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 27, 2001
- Date Received
- Jul 12, 2001
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii
- Device Class
- Class II
- Regulation Number
- 866.3780
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Bayer Diagnostics Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.